Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3114 Target Snapshot

Sucrase-isomaltase, intestinal · SINGLE PROTEIN · Rattus norvegicus

456Compounds
136Assays
4Approved Drugs
681.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P23739. Use UniProt P23739 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P23739 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Sucrase-isomaltase, intestinal as ChEMBL target CHEMBL3114, mapped to UniProt P23739. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Sucrase-isomaltase, intestinal
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL3114
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P23739
Sucrase-isomaltase, intestinal
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Sucrase-isomaltase, intestinal is the right protein anchor across sources, using UniProt P23739 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSucrase-isomaltase, intestinal
UniProt AccessionP23739
Component TypeProtein
Sequence Length1841 aa

Sucrase-isomaltase, intestinal

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Sucrase-isomaltase, intestinal, mapped to UniProt P23739. Sequence length is 1841 aa.

Mapped IDP23739
Review nameSucrase-isomaltase, intestinal
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

4
Approved
1
Phase III
3
Phase II
Assay Mix

Activity Type Distribution

IC50620.0
KI61.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL432221 9.82 Ki 0.15 Preclinical
CHEMBL120226 8.52 Ki 3.0 Preclinical
CHEMBL184028 8.46 IC50 3.5 Preclinical
CHEMBL268675 8.36 IC50 4.4 Preclinical
CHEMBL402196 8.3 IC50 5.0 Preclinical
CHEMBL121283 8.1 Ki 8.0 Preclinical
CHEMBL403239 8.07 IC50 8.5 Preclinical
CHEMBL120395 8.0 Ki 10.0 Preclinical
CHEMBL120489 7.8 Ki 16.0 Preclinical
CHEMBL415713 7.8 Ki 16.0 Preclinical
Distribution

pChEMBL Value Distribution

66
5.0
98
5.5
83
6.0
77
6.5
21
7.0
11
7.5
7
8.0
1
8.5
0
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

MIGLUSTAT
CHEMBL1029
Approved 2002
MIGLITOL
CHEMBL1561
Approved 1996
ACARBOSE
CHEMBL404271
Approved 1995
VOGLIBOSE
CHEMBL476960
Approved 1994
Assay Landscape

Assay Landscape

136
Total Assays
303
Tested Compounds
1
Assay Types
Binding — 136 assays, 303 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 114 227 5.8
assay format 11 37 5.5
cell membrane format 6 24 5.8
tissue-based format 3 14 5.2
cell-based format 2 1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine